{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:07:31Z","timestamp":1793844451346,"version":"4.6.1"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.survophthal.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:55:50Z","timestamp":1785995750000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The \u201cTap\u2013Drain\u201d model of central serous chorioretinopathy: Mechanistic staging and a corrective action-preventative action-based framework for disease modification"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-9390","authenticated-orcid":false,"given":"Ramesh","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Hande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishma","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niroj Kumar","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasiq","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.survophthal.2026.08.003_bib1","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1111\/aos.14683","article-title":"Pachychoroid spectrum disease","volume":"99","author":"Borooah","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101236","article-title":"Central serous chorioretinopathy: an evidence-based treatment guideline","volume":"101","author":"Feenstra","year":"2024","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"10.1016\/j.survophthal.2026.08.003_bib3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/eye.2010.130","article-title":"Central serous chorioretinopathy: an update on pathogenesis and treatment","volume":"24","author":"Gemenetzi","year":"2010","journal-title":"Eye (Lond)"},{"issue":"13","key":"10.1016\/j.survophthal.2026.08.003_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.10.13.6","article-title":"Acute central serous chorioretinopathy subtypes as assessed by multimodal imaging","volume":"10","author":"Arrigo","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.08.003_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","article-title":"Central serous chorioretinopathy international group. multimodal imaging-based central serous chorioretinopathy classification","volume":"4","author":"Chhablani","year":"2020","journal-title":"Ophthalmol Retin"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.oret.2022.10.001","article-title":"En face ultrawidefield OCT of the vortex vein system in central serous chorioretinopathy","volume":"7","author":"Ramtohul","year":"2023","journal-title":"Ophthalmol Retin"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.survophthal.2021.07.004","article-title":"Multimodal imaging in pachychoroid spectrum","volume":"67","author":"Safi","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","author":"Spaide","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.survophthal.2026.08.003_bib9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ajo.2015.02.002","article-title":"Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization","volume":"159","author":"Hage","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.08.003_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3928\/23258160-20220725-01","article-title":"Acute Versus Chronic Central Serous Chorioretinopathy: Classification Strategies and Management","volume":"53","author":"Arora","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"3","key":"10.1016\/j.survophthal.2026.08.003_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/ceo.14201","article-title":"Central serous chorioretinopathy: A review","volume":"51","author":"Fung","year":"2023","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib13","first-page":"26","article-title":"Central Serous Chorioretinopathy Classification","volume":"14","author":"Vilela","year":"2020","journal-title":"Pharm (Basel)"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00417-021-05452-1","article-title":"Central Serous Chorioretinopathy International Group. Validation of central serous chorioretinopathy multimodal imaging-based classification system","volume":"260","author":"Chhablani","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OPTH.S115685","article-title":"Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life","volume":"11","author":"Breukink","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.08.003_bib16","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/IAE.0000000000001729","article-title":"RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY","volume":"38","author":"Matet","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.08.003_bib17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2147\/OPTH.S242926","article-title":"Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy","volume":"14","author":"Mohabati","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","article-title":"Choroidal capillary and venous congestion in central serous chorioretinopathy","volume":"121","author":"Pr\u00fcnte","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.08.003_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41433-024-03253-4","article-title":"Pachychoroid disease: review and update","volume":"39","author":"Cheung","year":"2025","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00225936","article-title":"Indocyanine green angiography of central serous chorioretinopathy","volume":"9","author":"Hayashi","year":"1986","journal-title":"Int Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib22","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"issue":"Pt 3","key":"10.1016\/j.survophthal.2026.08.003_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/eye.1995.63","article-title":"Indocyanine green angiographic findings in central serous chorioretinopathy","volume":"9","author":"Piccolino","year":"1995","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/iovs.63.1.17","article-title":"Ultra-Widefield Indocyanine Green Angiography Reveals Patterns of Choroidal Venous Insufficiency Influencing Pachychoroid Disease","volume":"63","author":"Bacci","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.oret.2017.05.013","article-title":"Dilatation of Asymmetric Vortex Vein in Central Serous Chorioretinopathy","volume":"2","author":"Hiroe","year":"2018","journal-title":"Ophthalmol Retin"},{"issue":"6","key":"10.1016\/j.survophthal.2026.08.003_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjophthalmol-2020-316108","article-title":"Classification of pachychoroid disease on ultrawide-field indocyanine green angiography using auto-machine learning platform","volume":"105","author":"Kim","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.08.003_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.12.9.17","article-title":"Choroidal Vortex Vein Drainage System in Central Serous Chorioretinopathy Using Ultra-Widefield Optical Coherence Tomography Angiography","volume":"12","author":"Luo","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.08.003_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.oret.2023.10.007","article-title":"Choroidal Vascular Changes on Ultrawidefield Indocyanine Green Angiography in Central Serous Chorioretinopathy","volume":"8","author":"Pauleikhoff","year":"2024","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2026.08.003_bib29","series-title":"StatPearls [Internet]. Treasure Island (FL)","article-title":"Central Serous Chorioretinopathy. [Updated 2023 Aug 25]","author":"Gupta","year":"2025"},{"issue":"11","key":"10.1016\/j.survophthal.2026.08.003_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/bjo.59.11.631","article-title":"Segmental nature of the choroidal vasculature","volume":"59","author":"Hayreh","year":"1975","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib31","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/IAE.0000000000002931","article-title":"CHOROIDAL BLOOD FLOW: Review and Potential Explanation for the Choroidal Venous Anatomy Including the Vortex Vein System","volume":"40","author":"Spaide","year":"2020","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.survophthal.2026.08.003_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.oret.2020.07.011","article-title":"Scleral Thickness in Central Serous Chorioretinopathy","volume":"5","author":"Imanaga","year":"2021","journal-title":"Ophthalmol Retin"},{"issue":"11","key":"10.1016\/j.survophthal.2026.08.003_bib33","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1007\/s00417-022-05687-6","article-title":"A new insight into pachychoroid diseases: Remodeling of choroidal vasculature","volume":"260","author":"Kishi","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib34","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41598-021-85229-y","article-title":"A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2026.08.003_bib35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41433-021-01808-3","article-title":"Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment","volume":"36","author":"Kanda","year":"2022","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40942-023-00443-2","article-title":"Pathomechanisms in central serous chorioretinopathy: A recent update","volume":"9","author":"Zarnegar","year":"2023","journal-title":"Int J Retin Vitr"},{"issue":"9","key":"10.1016\/j.survophthal.2026.08.003_bib37","first-page":"605","article-title":"Indocyanine green angiography of central serous chorioretinopathy","volume":"62","author":"Chen","year":"1999","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib38","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","article-title":"Corticosteroids and central serous chorioretinopathy","volume":"109","author":"Carvalho-Recchia","year":"2002","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2026.08.003_bib39","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bjo.81.11.962","article-title":"Endogenous cortisol profile in patients with central serous chorioretinopathy","volume":"81","author":"Garg","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib40","first-page":"799","article-title":"Type A behavior and central serous chorioretinopathy","volume":"84","author":"Yannuzzi","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"9","key":"10.1016\/j.survophthal.2026.08.003_bib41","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/IAE.0b013e3182993f66","article-title":"Multimodal imaging of pigment epithelial detachment: a guide to evaluation","volume":"33","author":"Mrejen","year":"2013","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2026.08.003_bib42","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"PACHYCHOROID PIGMENT EPITHELIOPATHY","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2026.08.003_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Progress Retin Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-vision-102122-102907","article-title":"Central Serous Chorioretinopathy: Epidemiology, Genetics and Clinical Features","volume":"10","author":"Khan","year":"2024","journal-title":"Annu Rev Vision Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2026.08.003_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206646","article-title":"Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy","volume":"13","author":"Kishi","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40662-023-00349-y","article-title":"Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies","volume":"10","author":"Zhang","year":"2023","journal-title":"Eye Vis (Lond)"},{"issue":"6","key":"10.1016\/j.survophthal.2026.08.003_bib48","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3390\/jcm12062088","article-title":"Intervortex Venous Anastomosis in the Macula in Central Serous Chorioretinopathy Imaged by En Face Optical Coherence Tomography","volume":"12","author":"Fern\u00e1ndez-Vigo","year":"2023","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.survophthal.2026.08.003_bib49","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IAE.0b013e31820f4b39","article-title":"Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy","volume":"31","author":"Maruko","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.08.003_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2025.100252","article-title":"International consensuses and guidelines on central serous chorioretinopathy (CSC) by the Asia Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)","author":"Radke","year":"2025","journal-title":"Asia Pac J Ophthalmol (Phila"},{"issue":"7","key":"10.1016\/j.survophthal.2026.08.003_bib51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41433-019-0381-7","article-title":"Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options","volume":"33","author":"Sartini","year":"2019","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ajo.2014.11.011","article-title":"Optical density ratio in the subretinal fluid: differentiating chronic central serous chorioretinopathy and polypodial choroidal vasculopathy","volume":"159","author":"Baek","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.7.1.3","article-title":"Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study","volume":"7","author":"Kowalczuk","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000350231","article-title":"Quantitative and qualitative spectral domain optical coherence tomography analysis of subretinal deposits in patients with acute central serous retinopathy","volume":"230","author":"Landa","year":"2013","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/ijo.IJO_265_19","article-title":"Subretinal hyperreflective material in central serous chorioretinopathy","volume":"68","author":"Sahoo","year":"2020","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.08.003_bib56","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/s41433-025-03894-z","article-title":"Treatment of central serous chorioretinopathy: new options for an old disease","volume":"39","author":"Kim","year":"2025","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib57","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IAE.0000000000001192","article-title":"VACUOLE\u201d SIGN ADJACENT TO RETINAL PIGMENT EPITHELIAL DEFECTS ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH SUBRETINAL FIBRIN","volume":"37","author":"Rajesh","year":"2017","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000324701","article-title":"Central serous chorioretinopathy with subretinal deposition of fibrin-like material and its prompt response to ranibizumab injections","volume":"2","author":"Symeonidis","year":"2011","journal-title":"Case Rep Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib59","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2014.06.015","article-title":"Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography","volume":"158","author":"Yu","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.08.003_bib60","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IAE.0000000000002580","article-title":"FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY","volume":"40","author":"Han","year":"2020","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib61","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ophtha.2010.08.017","article-title":"Fundus autofluorescence and visual acuity in central serous chorioretinopathy","volume":"118","author":"Imamura","year":"2011","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib62","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/eye.2016.113","article-title":"Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity","volume":"30","author":"Lee","year":"2016","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2026.08.003_bib63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ophtha.2005.01.003","article-title":"Klancnik JM. Fundus autofluorescence and central serous chorioretinopathy","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.08.003_bib64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/OPTH.S39584","article-title":"Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy","volume":"7","author":"Ratanasukon","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.08.003_bib65","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0161-6420(95)30908-6","article-title":"Subretinal fibrosis in central serous chorioretinopathy","volume":"102","author":"Schatz","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.08.003_bib66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2024.04.025","article-title":"Pathogenesis of Central Serous Chorioretinopathy and the Link Between Choroidal Hyperpermeability and Retinal Pigment Epithelium Pump Reversal","volume":"266","author":"Fossataro","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.08.003_bib67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/meajo.MEAJO_125_19","article-title":"Bullous Central Serous Chorioretinopathy Associated with Retinal Pigment Epithelial Tear","volume":"27","author":"Kannan","year":"2020","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"16","key":"10.1016\/j.survophthal.2026.08.003_bib68","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037855","article-title":"Giant retinal pigment epithelial tear following photodynamic therapy for the bullous variant of central serous chorioretinopathy: A case report","volume":"103","author":"Kimura","year":"2024","journal-title":"Med (Baltim)"},{"issue":"3","key":"10.1016\/j.survophthal.2026.08.003_bib69","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/tjo.TJO-D-22-00150","article-title":"Retinal pigment epithelium tear in an idiopathic acute onset bullous central serous chorioretinopathy","volume":"13","author":"Ou","year":"2023","journal-title":"Taiwan J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.08.003_bib70","article-title":"Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review","volume":"13","author":"Sartini","year":"2020","journal-title":"Pharm (Basel)"},{"issue":"8","key":"10.1016\/j.survophthal.2026.08.003_bib71","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamaophthalmol.2015.1320","article-title":"Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography","volume":"133","author":"Bonini Filho","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib72","article-title":"Detection of Silent Type I Choroidal Neovascular Membrane in Chronic Central Serous Chorioretinopathy Using En Face Swept-Source Optical Coherence Tomography Angiography","volume":"2017","author":"Moussa","year":"2017","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40942-025-00761-7","article-title":"Choroidal neovascularization as a trigger for central serous chorioretinopathy","volume":"12","author":"Vienne-Jumeau","year":"2025","journal-title":"Int J Retin Vitr"},{"issue":"6","key":"10.1016\/j.survophthal.2026.08.003_bib74","article-title":"Interventions for central serous chorioretinopathy: a network meta-analysis","volume":"6","author":"Lange","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib75","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/2211-5056.362601","article-title":"Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification","volume":"12","author":"Jain","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00417-019-04486-w","article-title":"Corticosteroids usage and central serous chorioretinopathy: a meta-analysis","volume":"258","author":"Ge","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib78","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/j.jcjo.2017.10.032","article-title":"Central serous chorioretinopathy probably associated with isotretinoin in a keratoconus patient","volume":"53","author":"Buyuktortop","year":"2018","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib79","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/IAE.0b013e3181b7740f","article-title":"Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study","volume":"30","author":"French","year":"2010","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib80","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.survophthal.2025.01.017","article-title":"Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids","volume":"70","author":"Jain","year":"2025","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib81","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0002-9394(03)00076-X","article-title":"Central serous chorioretinopathy associated with administration of sympathomimetic agents","volume":"136","author":"Michael","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib82","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/IAE.0000000000000198","article-title":"Central serous chorioretinopathy in patients receiving exogenous testosterone therapy","volume":"34","author":"Nudleman","year":"2014","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12886-020-01499-6","article-title":"Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report","volume":"20","author":"Venkatesh","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib84","article-title":"Poor Sleep Quality Is the Risk Factor for Central Serous Chorioretinopathy","volume":"2018","author":"Ji","year":"2018","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":"Systemic findings associated with central serous chorioretinopathy","volume":"128","author":"Tittl","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib86","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1038\/s41598-021-82536-2","article-title":"Central serous chorioretinopathy in active endogenous Cushing\u2019s syndrome","volume":"11","author":"Brinks","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2026.08.003_bib87","article-title":"Pregnancy as a risk factor for central serous chorioretinopathy: A systematic review and meta-analysis","author":"Eriksen","year":"2025","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib88","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/aos.16782","article-title":"Is tobacco consumption a risk factor for central serous chorioretinopathy? A systematic review and meta-analysis","volume":"103","author":"Fakhril-Din","year":"2025","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.08.003_bib89","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/IAE.0000000000002117","article-title":"ASSOCIATION OF OBSTRUCTIVE SLEEP APNEA WITH CENTRAL SEROUS CHORIORETINOPATHY AND CHOROIDAL THICKNESS: A Systematic Review and Meta-Analysis","volume":"38","author":"Wu","year":"2018","journal-title":"Retina"},{"issue":"Pt 2","key":"10.1016\/j.survophthal.2026.08.003_bib90","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/eye.1990.48","article-title":"The uveal effusion syndrome and trans-scleral flow","volume":"4","author":"Forrester","year":"1990","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2026.08.003_bib91","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10384-024-01101-2","article-title":"Central serous chorioretinopathy and the sclera: what we have learned so far","volume":"68","author":"Koizumi","year":"2024","journal-title":"Jpn J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.08.003_bib92","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ophtha.2017.05.038","article-title":"Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2026.08.003_bib93","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/bjo.70.5.373","article-title":"Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings","volume":"70","author":"Rahi","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib94","article-title":"Central Serous Chorioretinopathy: Multimodal Imaging and Management Options","volume":"2020","author":"Iyer","year":"2020","journal-title":"Case Rep Ophthalmol Med"},{"issue":"8","key":"10.1016\/j.survophthal.2026.08.003_bib95","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","article-title":"Digital indocyanine green videoangiography of central serous chorioretinopathy","volume":"112","author":"Guyer","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.08.003_bib96","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ophtha.2016.03.017","article-title":"Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging","volume":"123","author":"Balaratnasingam","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.08.003_bib97","article-title":"Correlation between Choroidal Neovascularization Shown by OCT Angiography and Choroidal Thickness in Patients with Chronic Central Serous Chorioretinopathy","volume":"2017","author":"Go\u0142\u0119biewska","year":"2017","journal-title":"J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.08.003_bib98","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ajo.2015.06.016","article-title":"Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography","volume":"160","author":"Quaranta-El Maftouhi","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.08.003_bib99","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/eye.2016.79","article-title":"The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study","volume":"30","author":"Ozkaya","year":"2016","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.survophthal.2026.08.003_bib100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archopht.1996.01100130681007","article-title":"Robertson DM. The long-term outcome of central serous chorioretinopathy","volume":"114","author":"Yap","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.08.003_bib101","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0161-6420(95)30960-8","article-title":"Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy","volume":"102","author":"Gass","year":"1995","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib102","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00006982-200408000-00028","article-title":"Retinal pigment epithelial tear in a patient with central serous chorioretinopathy treated with corticosteroids","volume":"24","author":"Ishida","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.08.003_bib103","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2018.06.009","article-title":"Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization","volume":"193","author":"Shiragami","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib104","article-title":"Increased Risk of Central Serous Chorioretinopathy among Patients with Nonorganic Sleep Disturbance","volume":"2020","author":"Tien","year":"2020","journal-title":"J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.08.003_bib105","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3928\/23258160-20170630-07","article-title":"Early Focal Laser Photocoagulation in Acute Central Serous Chorioretinopathy: A Prospective, Randomized Study","volume":"48","author":"Ambiya","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"9","key":"10.1016\/j.survophthal.2026.08.003_bib106","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/jcm8091398","article-title":"Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset","volume":"8","author":"Gaw\u0119cki","year":"2019","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.survophthal.2026.08.003_bib107","first-page":"170","article-title":"Oral Eplerenone Versus Observation in the Management of Acute Central Serous Chorioretinopathy: A Prospective, Randomized Comparative Study","volume":"13","author":"Venkatesh","year":"2020","journal-title":"Pharm (Basel)"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib108","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/17469899.2024.2336241","article-title":"Current and emerging treatment options for central serous chorioretinopathy","volume":"19","author":"Borselli","year":"2024","journal-title":"Expert Rev Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib109","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib110","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.08.003_bib111","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","article-title":"Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial","volume":"233","author":"van Rijssen","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib112","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/2008-322X.180706","article-title":"Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy","volume":"11","author":"Naseripour","year":"2016","journal-title":"J Ophthalmic Vis Res"},{"issue":"10262","key":"10.1016\/j.survophthal.2026.08.003_bib113","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/S0140-6736(20)32327-8","article-title":"Eplerenone for chronic central serous chorioretinopathy","volume":"396","author":"Stanescu-Segall","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib114","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11325-007-0112-3","article-title":"Central serous chorioretinopathy and risk for obstructive sleep apnea","volume":"11","author":"Leveque","year":"2007","journal-title":"Sleep Breath"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2017.06.008","article-title":"Central serous chorioretinopathy and glucocorticoids: an update on evidence for association","volume":"63","author":"Nicholson","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.08.003_bib116","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","article-title":"SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina"},{"issue":"10220","key":"10.1016\/j.survophthal.2026.08.003_bib117","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(19)32981-2","article-title":"Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Lotery","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00417-015-2989-z","article-title":"Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy","volume":"254","author":"Shulman","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib119","article-title":"Efficacy of oral rifampicin in chronic central serous chorioretinopathy","volume":"10","author":"Venkatesh","year":"2018","journal-title":"Ther Adv Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib120","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.3390\/jcm15103905","article-title":"Effects of Selective Retina Therapy on Central Serous Chorioretinopathy with Serous Pigment Epithelial Detachments","volume":"15","author":"Kim","year":"2026","journal-title":"JCM"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12886-025-04581-z","article-title":"Long-term outcomes of titration-guided focal selective retina therapy for chronic central serous chorioretinopathy: retrospective real-world data analysis","volume":"26","author":"Lindziute","year":"2026","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib122","article-title":"Efficacy of subthreshold micropulse laser for chronic central serous chorioretinopathy: A meta-analysis","volume":"39","author":"Li","year":"2022","journal-title":"Photo Photodyn Ther"},{"issue":"2","key":"10.1016\/j.survophthal.2026.08.003_bib123","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/eye.2014.315","article-title":"Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome","volume":"29","author":"Yadav","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2026.08.003_bib124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2025.11.039","article-title":"Subretinal Fluid Duration and Clinical Outcomes in Central Serous Chorioretinopathy: An Analysis of Time-to-Photodynamic Therapy","volume":"283","author":"Funatsu","year":"2026","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.08.003_bib125","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1007\/s10792-023-02822-y","article-title":"Early versus delayed photodynamic therapy for chronic central serous chorioretinopathy","volume":"43","author":"Katz","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.08.003_bib126","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/s41433-022-02370-2","article-title":"Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy","volume":"37","author":"Khandhadia","year":"2023","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.survophthal.2026.08.003_bib127","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00417-022-05836-x","article-title":"Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3","volume":"261","author":"Feenstra","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.08.003_bib128","first-page":"336","article-title":"Oral Treatment of Central Serous Chorioretinopathy Patients Using Propranolol Tablets","volume":"13","author":"Chen","year":"2020","journal-title":"Pharm (Basel)"},{"issue":"4","key":"10.1016\/j.survophthal.2026.08.003_bib129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3349\/ymj.2022.63.4.365","article-title":"Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy","volume":"63","author":"Han","year":"2022","journal-title":"Yonsei Med J"},{"issue":"9","key":"10.1016\/j.survophthal.2026.08.003_bib130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/IAE.0b013e31821c3ef6","article-title":"Oral mifepristone for chronic central serous chorioretinopathy","volume":"31","author":"Nielsen","year":"2011","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2026.08.003_bib131","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/08820538.2024.2308808","article-title":"Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy without Choroidal Neovascular Membrane - a Pilot Study","volume":"39","author":"Ramamurthy","year":"2024","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib132","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2025.12.007","article-title":"A Randomized-Controlled Trial of the Efficacy, Safety and Tolerability of Intravitreal Brolucizumab in Patients With Chronic Central Serous Chorioretinopathy With Persistent Fluid in the Absence of Choroidal Neovascular Membrane\u2014BRICS Trial Report II","volume":"283","author":"Ramamurthy","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.08.003_bib133","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ajo.2024.08.040","article-title":"Targeting the Tie-2 Receptor With Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding","volume":"269","author":"R\u00e4m\u00f6","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245342","article-title":"Short-term effect of anti-VEGF for chronic central serous chorioretinopathy according to the presence of choroidal neovascularization using optical coherence tomography angiography","volume":"16","author":"Song","year":"2021","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib135","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/s41433-021-01778-6","article-title":"Type one macular neovascularization in central serous chorioretinopathy: Short-term response to anti-vascular endothelial growth factor therapy","volume":"36","author":"Lejoyeux","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2026.08.003_bib136","article-title":"Detection of Silent Type I Choroidal Neovascular Membrane in Chronic Central Serous Chorioretinopathy Using En Face Swept-Source Optical Coherence Tomography Angiography","volume":"2017","author":"Moussa","year":"2017","journal-title":"J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.08.003_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011841","article-title":"Interventions for central serous chorioretinopathy: a network meta-analysis","volume":"2015","author":"Salehi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.survophthal.2026.08.003_bib138","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0161-6420(02)01157-0","article-title":"Acetazolamide for central serous retinopathy","volume":"109","author":"Pikkel","year":"2002","journal-title":"Ophthalmology"},{"issue":"13","key":"10.1016\/j.survophthal.2026.08.003_bib139","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.9.13.6","article-title":"Efficacy of Topical Carbonic Anhydrase Inhibitors in Reducing Duration of Chronic Central Serous Chorioretinopathy","volume":"9","author":"Liew","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.08.003_bib140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40662-016-0055-5","article-title":"Scleral resection in chronic central serous chorioretinopathy complicated by exudative retinal detachment","volume":"3","author":"Venkatesh","year":"2016","journal-title":"Eye Vis (Lond)"},{"issue":"10","key":"10.1016\/j.survophthal.2026.08.003_bib141","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4103\/ijo.IJO_1448_21","article-title":"Anxiolytics in the treatment of central serous chorioretinopathy","volume":"69","author":"Dudani","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.08.003_bib142","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.4103\/ijo.IJO_3499_20","article-title":"Effect of short-term meditation training in central serous chorioretinopathy","volume":"69","author":"Nongrem","year":"2021","journal-title":"Indian J Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:12:14Z","timestamp":1786162334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":142,"alternative-id":["S0039625726001177"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.08.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u201cTap\u2013Drain\u201d model of central serous chorioretinopathy: Mechanistic staging and a corrective action-preventative action-based framework for disease modification","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}